Dipyrone and agranulocytosis: what is the risk?

Lancet. 2003 Mar 15;361(9361):968-9. doi: 10.1016/S0140-6736(03)12751-1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Agranulocytosis / chemically induced*
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Dipyrone / adverse effects*
  • Humans
  • Incidence
  • Risk
  • Sweden

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Dipyrone